One Medical Group

SOLLIS HEALTH ANNOUNCES NEW CHIEF OPERATING OFFICER

Retrieved on: 
Wednesday, December 13, 2023
Oscar Health, Michael Sollis, One Medical Group, University of California, Berkeley, Insurance, Harvard College, MBA, MPH, Growth, Ye, UC, Health, Nursing, Economics

NEW YORK, Dec. 13, 2023 /PRNewswire/ -- Sollis Health, the first and only concierge urgent and emergency care provider, has named Jia Jia Ye as Chief Operating Officer, effective immediately. As the company's COO, Ye will ensure that Sollis Health delivers unparalleled clinical quality and member experience, with the brand's continued national expansion and growth.

Key Points: 
  • Medical concierge provider taps former Oscar Health and One Medical Executive, Jia Jia Ye
    NEW YORK, Dec. 13, 2023 /PRNewswire/ -- Sollis Health , the first and only concierge urgent and emergency care provider, has named Jia Jia Ye as Chief Operating Officer, effective immediately.
  • As the company's COO, Ye will ensure that Sollis Health delivers unparalleled clinical quality and member experience, with the brand's continued national expansion and growth.
  • "I am confident that with Jia Jia's expertise, Sollis Health will continue delivering the highest quality of care and capability."
  • "I'm thrilled to join Sollis Health and help expand our reach, bringing top-tier clinical care and an exceptional member experience to more people," said Ye.

LL Flooring Announces Leadership Appointments

Retrieved on: 
Thursday, July 6, 2023
Home Goods, Architecture, Commercial Building & Real Estate, Construction & Property, Online Retail, Interior Design, Retail, Residential Building & Real Estate, Knowledge, Universe, American Eagle Outfitters, RL, The Coca-Cola Company, Interim, GPS, LL Flooring, AEO, North Coast Women's Care Medical Group, Inc. v. Superior Court, Gap, Kraft Foods, Senior, Marketing, Martech, WPP, Delta Air Lines, KinderCare Learning Centers, LL, Organization, Ralph Lauren Corporation, One Medical Group, KHC, CRM, CFO, Growth, F45, System, Principal, Integration, NYSE, California Closets, Management, Sales, Ogilvy

LL Flooring Holdings, Inc. (“LL Flooring” or “Company”) (NYSE: LL), a leading specialty retailer of hard-surface flooring in the U.S., today announced three new leadership team appointments, all effective July 10, 2023.

Key Points: 
  • LL Flooring Holdings, Inc. (“LL Flooring” or “Company”) (NYSE: LL), a leading specialty retailer of hard-surface flooring in the U.S., today announced three new leadership team appointments, all effective July 10, 2023.
  • Charles Tyson, President and Chief Executive Officer, said, “The Board of Directors and I are pleased to welcome an executive of Bob’s caliber as LL Flooring’s next CFO, and look forward to benefitting from his deep retail, financial and leadership experience.
  • I am thrilled to be joining the Company and look forward to working with the leadership and field teams to maximize growth and optimize the customer experience.”
    Ms. Massaro said, “I am excited to join LL Flooring and to oversee its marketing initiatives as I leverage my prior experience and expertise to deliver the best outcome for LL Flooring and all of our stakeholders.
  • In addition, Mr. Wadhams spent over twelve years in field leadership positions with Gap, Inc. (NYSE: GPS).

Nectar Life Sciences Assembles Business Advisory Board of Consumer Goods and Health Services Industry Titans to Drive Business Expansion

Retrieved on: 
Monday, June 12, 2023
Medical Devices, Health, Telemedicine, Virtual Medicine, Health Technology, Research, Science, Allergy, FARE, Education, Food allergy, Tend, Olly, Emotion, The Co Founder, Patient, One Medical Group, Ecover, Maharashtra University of Health Sciences, Food, Dentistry, Pharmaceutical industry, Nursing, Management, Nectar

Nectar Life Sciences , an allergy-focused healthcare holding company, announced today that they added four business experts to their business advisory board.

Key Points: 
  • Nectar Life Sciences , an allergy-focused healthcare holding company, announced today that they added four business experts to their business advisory board.
  • The board is comprised of leaders in consumer products, health services, and patient advocacy industries.
  • Their goal is to advise Nectar on how to most effectively bridge best-in-class business practices with the highest quality healthcare.
  • Members of the business advisory board include:
    Andy Grover: Andy is the Co-Founder and Chief Development Officer at Tend, the dental brand bringing a hospitality mindset to oral health.

One Medical Joins Amazon to Make It Easier for People to Get and Stay Healthier

Retrieved on: 
Wednesday, February 22, 2023
Online Retail, Retail, Health, Telemedicine, Virtual Medicine, Practice Management, General Health, 1Life Healthcare, Health Insurance Portability and Accountability Act, Accountability Act, Insurance, Mental, Acquisition, Privacy, Thought, Patient, Orientation, AMZN, Protected health information, Conditional sentence, HIPAA, Medicare, Pediatrics, Roger Hawkins (drummer), Pharmacy, One Medical Group, Mental health, Medicine, Health insurance, Nursing, Pharmaceutical industry, Online shopping, Hospital, Amazon

Today, Amazon (NASDAQ: AMZN) and 1Life Healthcare, Inc. (NASDAQ: ONEM, “One Medical”) announced that Amazon completed its acquisition of One Medical.

Key Points: 
  • Today, Amazon (NASDAQ: AMZN) and 1Life Healthcare, Inc. (NASDAQ: ONEM, “One Medical”) announced that Amazon completed its acquisition of One Medical.
  • “One Medical has set the bar for what a quality, convenient, and affordable primary care experience should be like.
  • One Medical members can continue to count on One Medical for the high-quality care and high-level of service they receive.
  • One Medical looks forward to continuing to increase access to care and improve health outcomes with the support of Amazon.

Adaptive Phage Therapeutics Appoints Edward Fang as Chief Medical Officer

Retrieved on: 
Tuesday, October 25, 2022
Health, Infectious Diseases, Other Health, Clinical Trials, Pharmaceutical, Biotechnology, One Medical Group, Time, Mayo Clinic, Therapy, PST, Novozymes, Infection, Genetically modified bacteria, Defense Health Agency, NIH, Investigational New Drug, CAPT, Collection, University, APT, VC, United States Department of Defense, MD, National, CEO, Trius Therapeutics, Clinical trial, DFO, Stanford University, FDA, DHA, Kaiser Permanente, Leadership, Pharmaceutical industry, Medicine, Defense

Adaptive Phage Therapeutics, Inc. (APT), a clinical-stage biotechnology company advancing a phage bank, the worlds largest therapeutic phage initiative for treatment of bacterial infectious diseases, today announced the appointment of Edward Fang, M.D.

Key Points: 
  • Adaptive Phage Therapeutics, Inc. (APT), a clinical-stage biotechnology company advancing a phage bank, the worlds largest therapeutic phage initiative for treatment of bacterial infectious diseases, today announced the appointment of Edward Fang, M.D.
  • I am excited to welcome Dr. Fang, who brings broad expertise in therapeutic approaches to bacterial infectious disease and clinical trial execution to APT, stated Greg Merril, CEO and Co-Founder of Adaptive Phage Therapeutics.
  • I am thrilled to join Adaptive Phage Therapeutics in their battle to solve one of the greatest health challenges of our time multidrug-resistant bacterial infections a challenge that has only grown in difficulty with the consistent decline in antibiotic effectiveness and paucity in new product development, commented Edward Fang, M.D., Chief Medical Officer.
  • Dr. Fang previously served in clinical development management roles at Trius Therapeutics and Cerexa and was a practicing physician at One Medical Group and Kaiser Permanente Medical Group.

Small Door announces expansion of reimagined veterinary care with three new NYC locations

Retrieved on: 
Wednesday, November 3, 2021
Veterinarian, Florent Peyre, Third Avenue, PETS, Columbus Avenue, CEO, Premium Plus, CityMD, One Medical Group, Telehealth, Health insurance

NEW YORK, Nov. 3, 2021 /PRNewswire-PRWeb/ --Small Door Veterinary, a tech-enabled, hospitality-driven veterinary care provider, today announces three additional locations in New York City.

Key Points: 
  • NEW YORK, Nov. 3, 2021 /PRNewswire-PRWeb/ --Small Door Veterinary, a tech-enabled, hospitality-driven veterinary care provider, today announces three additional locations in New York City.
  • Most recently, in August 2021, Small Door opened its second practice on the Upper East Side (1231 3rd Avenue).
  • A universal plan offers access to Small Door's promise of exceptional and transparent veterinary care - increased access and clear explanations behind all services and bills.
  • Small Door offers membership-based veterinary care designed with human standards that are better for pets, pet parents, and veterinarians.